Hisamitsu Pharmaceutical Co Inc

TSE:4530 (Japan)   Ordinary Shares
円 3796.00 (0%) May 17
20.96
P/B:
1.08
Market Cap:
円 287.52B ($ 1.84B)
Enterprise V:
円 164.30B ($ 1.05B)
Volume:
93.10K
Avg Vol (2M):
182.15K
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hisamitsu Pharmaceutical Co Inc ( TSE:4530 ) from 1990 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hisamitsu Pharmaceutical stock (TSE:4530) PE ratio as of May 17 2024 is 20.96. More Details

Hisamitsu Pharmaceutical Co Inc (TSE:4530) PE Ratio (TTM) Chart

To

Hisamitsu Pharmaceutical Co Inc (TSE:4530) PE Ratio (TTM) Historical Data

Total 1249
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Hisamitsu Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-17 21.0 2024-03-12 21.1
2024-05-17 21.0 2024-03-11 21.1
2024-05-16 21.0 2024-03-08 21.2
2024-05-15 20.9 2024-03-07 21.0
2024-05-14 21.0 2024-03-06 21.0
2024-05-13 20.9 2024-03-05 20.9
2024-05-10 21.1 2024-03-04 21.2
2024-05-09 21.2 2024-03-01 21.4
2024-05-08 20.9 2024-02-29 21.4
2024-05-07 20.8 2024-02-28 21.6
2024-05-02 20.7 2024-02-27 21.6
2024-05-01 21.1 2024-02-26 21.8
2024-04-30 21.1 2024-02-23 21.5
2024-04-26 20.9 2024-02-22 21.5
2024-04-25 20.5 2024-02-21 21.6
2024-04-24 20.7 2024-02-20 21.8
2024-04-23 20.9 2024-02-19 21.8
2024-04-22 20.9 2024-02-16 21.9
2024-04-19 20.5 2024-02-15 21.5
2024-04-18 20.6 2024-02-14 22.1
2024-04-17 20.6 2024-02-13 22.4
2024-04-16 21.0 2024-02-12 22.4
2024-04-15 21.1 2024-02-09 22.4
2024-04-12 21.6 2024-02-08 22.4
2024-04-11 21.8 2024-02-07 22.5
2024-04-10 21.9 2024-02-06 22.5
2024-04-09 21.9 2024-02-05 22.9
2024-04-08 21.9 2024-02-02 22.8
2024-04-05 21.7 2024-02-01 22.6
2024-04-04 21.4 2024-01-31 22.8
2024-04-03 21.3 2024-01-30 22.6
2024-04-02 21.2 2024-01-29 22.8
2024-04-01 21.6 2024-01-26 22.8
2024-03-29 21.9 2024-01-25 22.7
2024-03-28 21.6 2024-01-24 22.8
2024-03-27 22.1 2024-01-23 22.7
2024-03-26 22.1 2024-01-22 22.8
2024-03-25 22.0 2024-01-19 22.6
2024-03-22 22.3 2024-01-18 23.1
2024-03-21 22.1 2024-01-17 23.6
2024-03-19 22.1 2024-01-16 23.6
2024-03-18 22.0 2024-01-15 24.1
2024-03-15 21.6 2024-01-12 24.0
2024-03-14 21.1 2024-01-11 24.7
2024-03-13 21.0 2024-01-10 24.4

Hisamitsu Pharmaceutical Co Inc (TSE:4530) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.